Application of biological agents in the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis

Application of biological agents in the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) has been traditionally treated using glucocorticoids and immunosuppressants. However, these treatment modes are associated with high recurrence AAV rates and adverse reactions. Therefore, treatment strategies for AAV need to be...

Full description

Bibliographic Details
Main Authors: Weijun Liu, Guanyuan Tian, Chao Chen, Mingying Zhang, Zhanmao Chen, Tietao Chen, Zhibin Lin, Wuzhong Wu, Yiqaing Wu, Kefei Wu, Qinghua Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-05-01
Series:Frontiers in Pharmacology
Subjects:
anti-neutrophil cytoplasmic antibody
biological agents
vasculitis
treatment
microscopic polyangiitis
granulomatosis with polyangiitis
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1378384/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2024.1378384/full

Similar Items